News

/News/

Swann welcomes Remdesivir for treatment of Covid-19

Health Minister Robin Swann welcomes the announcement today that the anti-viral drug Remdesivir will be available for the treatment of Covid-19. Remdesivir is an innovative drug that is currently undergoing clinical trials around the world, including the UK. International studies show the drug can shorten recovery time from Covid-19 by about four days. The Minister [...]

By |2020-05-26T12:05:44+01:00May 26th, 2020|NIH News, Regional News|0 Comments

Blue Earth Diagnostics CEO Jonathan Allis Appointed Chair of UK Rapid Testing Consortium (UK-RTC) for COVID-19 by UK Department of Health and Social Care

OXFORD, England & BURLINGTON, Mass.--(BUSINESS WIRE)--Blue Earth Diagnostics, a Bracco company focused on molecular imaging diagnostics, today announced that its CEO, Dr Jonathan Allis, has been appointed as Chair of the UK Rapid Testing Consortium (UK-RTC) for COVID-19 by the UK Department of Health and Social Care (DHSC). The UK-RTC has been formed to draw [...]

By |2020-05-26T10:22:51+01:00May 26th, 2020|NIH News|Comments Off on Blue Earth Diagnostics CEO Jonathan Allis Appointed Chair of UK Rapid Testing Consortium (UK-RTC) for COVID-19 by UK Department of Health and Social Care

UK Nutritional Bar Market was Valued $ 1.1 Billion in 2019 & is Projected to Cross $ 1.5 Billion by 2025 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "UK Nutritional Bar Market, By Product Type (Breakfast Bars, Snack Bars, Protein Bars & Others), By Distribution Channel, By Company, By Region, Competition, Forecast & Opportunities, 2025" report has been added to ResearchAndMarkets.com's offering. UK nutritional bar market was valued $ 1.1 billion in 2019 and is projected to cross $ 1.5 billion [...]

By |2020-05-26T10:22:47+01:00May 26th, 2020|NIH News|Comments Off on UK Nutritional Bar Market was Valued $ 1.1 Billion in 2019 & is Projected to Cross $ 1.5 Billion by 2025 – ResearchAndMarkets.com

Positive Recommendation by NICE for first anti-CGRP migraine therapy: AJOVY®▼ (fremanezumab)

TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Europe BV an affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that the National Institute for Health and Care Excellence (NICE) has recommended AJOVY (fremanezumab) in its Final Appraisal Document (FAD) for the prevention of migraine in adults with chronic migraine. NICE recommends AJOVY® for chronic [...]

By |2020-05-26T10:22:43+01:00May 26th, 2020|NIH News|Comments Off on Positive Recommendation by NICE for first anti-CGRP migraine therapy: AJOVY®▼ (fremanezumab)

Shionogi Announces Launch of Mulpleo® (lusutrombopag) in the UK, for the Treatment of Severe Thrombocytopenia in Adult Patients With Chronic Liver Disease Undergoing Invasive Procedures

Mulpleo (lusutrombopag) is the first licensed treatment now available through the National Health Service (NHS) in the UK to treat severe thrombocytopenia in adults with chronic liver disease (CLD) who are undergoing invasive procedures, and has also been approved for funding across the health services in England & Wales, Scotland and Northern Ireland1,2,3 Thrombocytopenia is [...]

By |2020-05-26T10:22:38+01:00May 26th, 2020|NIH News|Comments Off on Shionogi Announces Launch of Mulpleo® (lusutrombopag) in the UK, for the Treatment of Severe Thrombocytopenia in Adult Patients With Chronic Liver Disease Undergoing Invasive Procedures

Vertex Confirms Wales Offer Accepted for Access to All Licensed Cystic Fibrosis Medicines

-Eligible patients in Wales will soon have access to ORKAMBI® (lumacaftor/ivacaftor) and SYMKEVI® (tezacaftor/ivacaftor), expanded access to KALYDECO® (ivacaftor) under same terms as NHS England agreement- LONDON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today confirms that NHS Wales has accepted an offer for all currently licensed Vertex cystic fibrosis (CF) medicines and any future indications of [...]

By |2020-05-27T09:49:23+01:00May 26th, 2020|NIH News|Comments Off on Vertex Confirms Wales Offer Accepted for Access to All Licensed Cystic Fibrosis Medicines

Community Pharmacy Can Play a Leading Role in the Re-building of the Health and Social Care Sector as COVID-19 Surge Plans Reduce

The Chief Executive of Community Pharmacy NI, Gerard Greene, has said that the community pharmacy network here can provide significant support in getting the health and social care system back on its feet after COVID-19 surge plans have been downgraded.   The call comes as the Health Minister Robin Swann has announced that he will [...]

By |2020-05-20T16:42:20+01:00May 20th, 2020|NIH News, Regional News|0 Comments

Parents of infants urged to look after their own wellbeing

The Public Health Agency (PHA) is reminding parents to be kind to themselves during the COVID-19 pandemic, and in turn they will be helping to protect their infant’s mental health. Infant mental health is the term used to describe the capacity of a child, during the first three years of life. It is the capacity [...]

By |2020-05-20T12:43:46+01:00May 20th, 2020|NIH News, Regional News|0 Comments

Parents urged not to ignore signs of type 1 diabetes during COVID-19 pandemic

The Public Health Agency (PHA), Diabetes UK and the Diabetes Network are urging parents and carers not to ignore the signs of type 1 diabetes during the COVID-19 pandemic, and are reassuring them that help and support is available for those who need medical attention. Type 1 diabetes cannot be prevented and occurs when the [...]

By |2020-05-20T12:41:03+01:00May 20th, 2020|NIH News, Regional News|0 Comments

Swann Publishes Mental Health Action Plan

Health Minister Robin Swann has published the Mental Health Action Plan as part of his commitment to improve the mental health of the population in Northern Ireland. The Action Plan contains 38 actions, including a commitment to produce a mental health strategy, which will include a comprehensive funding plan for mental health. There is also [...]

By |2020-05-20T12:00:18+01:00May 20th, 2020|NIH News, Regional News|0 Comments